1. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023) Authors: Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 2(2023) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PPARalpha regulates the production of serum Vanin‐1 by liver. Issue 22 (15th October 2013) Authors: Rommelaere, Samuel; Millet, Virginie; Gensollen, Thomas; Bourges, Christophe; Eeckhoute, Jérôme; Hennuyer, Nathalie; Baugé, Eric; Chasson, Lionel; Cacciatore, Ivana; Staels, Bart; Pitari, Giuseppina; Galland, Franck; Naquet, Philippe Journal: FEBS letters Issue: Volume 587:Issue 22(2013) Page Start: 3742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Resolving mechanisms of immune‐mediated disease in primary CD4 T cells. Issue 5 (1st April 2020) Authors: Bourges, Christophe; Groff, Abigail F; Burren, Oliver S; Gerhardinger, Chiara; Mattioli, Kaia; Hutchinson, Anna; Hu, Theodore; Anand, Tanmay; Epping, Madeline W; Wallace, Chris; Smith, Kenneth GC; Rinn, John L; Lee, James C Journal: EMBO molecular medicine Issue: Volume 12:Issue 5(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗